Correlations of norepinephrine release in the paraventricular nucleus with plasma corticosterone and leptin after systemic lipopolysaccharide: Blockade by soluble IL-1 receptor

Brain Research

Volumn 867, Issue 1-2, 2000, Pages 180-187

  Francis, Joseph ^a   MohanKumar, Sheba M J ^a   MohanKumar, P S ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Corticosterone; Leptin; Lipopolysaccharide; Norepinephrine; Paraventricular nucleus

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; LEPTIN; LIPOPOLYSACCHARIDE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; INFECTION; MALE; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ANOREXIA; CATHETERIZATION; CORTICOSTERONE; LEPTIN; LIPOPOLYSACCHARIDES; MALE; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1; SOLUBILITY;

EID: 0034625698     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02311-8     Document Type: Article

References (40)

1. Berczi I. Neuroendocrine defense in endotoxin shock (a review). Acta Microbiol. Hung. 40:1993;265-302.
2. Bray G.A., York D.A. The MONA LISA hypothesis in the time of leptin. Recent Prog. Horm. Res. 53:1998;95-118.
3. Carlson S.L., Felten D.L., Livnat S., Felten S.Y. Alterations of monoamines in specific central autonomic nuclei following immunization in mice. Brain Behav. Immun. 1:1987;52-63.
4. Dinarello C.A. Interleukin-1 and its biologically related cytokines. Dixon F.J. Advances in Immunology. Vol. 44:1989;153-205 Academic Press, San Diego, CA.
5. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261:1992;964-969.
6. Elenkov I.J., Kiss J., Stark E., Bertok L. CRF-dependent and CRF-independent mechanisms involved in hypophysial-adrenal system activation by bacterial endotoxin. Acta Physiol. Hung. 79:1992;355-363.
7. Elenkov I.J., Kovacs K., Kiss J., Bertok L., Vizi E.S. Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesions of the paraventricular nucleus. J. Endocrinol. 133:1992;231-236.
8. Elmquist J.K., Saper C.B. Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J. Comp. Neurol. 374:1996;315-331.
9. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
10. Ericsson A., Arias C., Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 17:1997;7166-7179.
11. Finck B.N., Kelley K.W., Dantzer R., Johnson R.W. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology. 139:1998;2278-2283.
12. Francis J., MohanKumar P.S., MohanKumar S.M., Quadri S.K. Systemic administration of lipopolysaccharide increases plasma leptin levels. Endocrine. 10:1999;291-295.
13. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 43:1997;357-364.
14. Janig W. Neurobiology of visceral afferent neurons: neuroanatomy, functions, organ regulations and sensations. Biol. Psychol. 42:1996;29-51.
15. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 133:1993;815-821.
16. Kosaki A., Yamada K., Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes. 45:1996;1744-1749.
17. Lavicky J., Dunn A.J. Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J. Neurosci. Res. 40:1995;407-413.
18. Lee S., Barbanel G., Rivier C. Systemic endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with corticotropin-releasing factor and vasopressin gene transcripts. Brain Res. 705:1995;136-148.
19. Leibowitz S.F. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci. Biobehav. Rev. 12:1988;101-109.
20. Maier S.F., Goehler L.E., Fleshner M., Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. NY Acad. Sci. 840:1998;289-300.
21. Mefford I.N., Heyes M.P. Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin. J. Neuroimmunol. 27:1990;55-61.
22. MohanKumar P.S., Quadri S.K. Systemic administration of interleukin-1 stimulates norepinephrine release in the paraventricular nucleus. Life Sci. 52:1993;1961-1967.
23. MohanKumar P.S., Thyagarajan S., Quadri S.K. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci. 48:1991;925-930.
24. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res. Bull. 47:1998;29-34.
25. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Res. 824:1999;232-237.
26. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd Edition, 1986, Academic Press, New York.
27. Petrusz P., Merchenthaler I. The corticotropin-releasing factor system. Nemeroff C.B. Neuroendocrinology. 1992;129-184 CRC Press, Boca Raton, FL.
28. Pozzoli G., Costa A., Grimaldi M., Schettini G., Preziosi P., Grossman A., Navarra P. Lipopolysaccharide modulation of eicosanoid and corticotrophin-releasing hormone release from rat hypothalamic explants and astrocyte cultures in vitro: evidence for the involvement of prostaglandin E2 but not prostaglandin F2 alpha and lack of effect of nerve growth factor. J. Endocrinol. 140:1994;103-109.
29. Quan N., Sundar S.K., Weiss J.M. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol. 49:1994;125-134.
30. Rayner D.V., Simon E., Duncan J.S., Trayhurn P. Hyperleptinaemia in mice induced by administration of the tyrosine hydroxylase inhibitor alpha-methyl-p-tyrosine. FEBS Lett. 429:1998;395-398.
31. Reichlin S. Neuroendocrinology of infection and the innate immune system. Recent Prog. Horm. Res. 54:1999;133-183.
32. Reichlin S. Is leptin a secretion of the brain? J. Clin. Endocrinol. Metab. 84:1999;2267-2269.
33. Rivier C. Role of Endotoxin and IL-1 in modulating ACTH, LH, and sex steroid secretion. Porter J.C., Jezova D. Advances in Experimental Biology and Medicine. Vol. 274:1990;295-301 Plenum Press, New York.
34. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J. 3rd, Flier J.S., Lowell B.B., Fraker D.L., Alexander H.R. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 185:1997;171-175.
35. Szafarczyk A., Malaval F., Laurent A., Gibaud R., Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology. 121:1987;883-892.
36. Szafarczyk A., Guillaume V., Conte-Devolx B., Alonso G., Malaval F., Pares-Herbute N., Oliver C., Assenmacher I. Central catecholaminergic system stimulates secretion of CRH at different sites. Am. J. Physiol. 255:1988;E463-E468.
37. Tilders F.J., Derijk R.H., Van Dam A.M., Vincent V.A., Schotanus K., Persoons J.H. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology. 19:1994;209-232.
38. Turnbull A.V., Rivier C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1999;1-71.
39. Vellucci S.V., Parrott R.F. Expression of mRNAs for vasopressin, oxytocin and corticotrophin releasing hormone in the hypothalamus, and of cyclooxygenases-1 and -2 in the cerebral vasculature, of endotoxin-challenged pigs. Neuropeptides. 32:1998;439-446.
40. Wiesner G., Vaz M., Collier G., Seals D., Kaye D., Jennings G., Lambert G., Wilkinson D., Esler M. Leptin is released from the human brain: influence of adiposity and gender. J. Clin. Endocrinol. Metab. 84:1999;2270-2274.